×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
CMPX – compass therapeutics, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
CMPX
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
4/4
08:14 am
cmpx
Compass Therapeutics, Inc. (NASDAQ: CMPX) had its price target raised by analysts at HC Wainwright from $10.00 to $24.00. They now have a "buy" rating on the stock.
Medium
Report
Compass Therapeutics, Inc. (NASDAQ: CMPX) had its price target raised by analysts at HC Wainwright from $10.00 to $24.00. They now have a "buy" rating on the stock.
4/3
07:26 am
cmpx
Compass Therapeutics, Inc. (NASDAQ: CMPX) was upgraded by analysts at Leerink Partnrs from a "hold" rating to a "strong-buy" rating.
Low
Report
Compass Therapeutics, Inc. (NASDAQ: CMPX) was upgraded by analysts at Leerink Partnrs from a "hold" rating to a "strong-buy" rating.
4/2
04:05 pm
cmpx
Compass Therapeutics to Participate in the Stifel 2025 Virtual Targeted Oncology Forum
Medium
Report
Compass Therapeutics to Participate in the Stifel 2025 Virtual Targeted Oncology Forum
4/2
11:50 am
cmpx
Compass Therapeutics, Inc. (NASDAQ: CMPX) had its "buy" rating re-affirmed by analysts at Guggenheim. They now have a $12.00 price target on the stock.
High
Report
Compass Therapeutics, Inc. (NASDAQ: CMPX) had its "buy" rating re-affirmed by analysts at Guggenheim. They now have a $12.00 price target on the stock.
4/2
08:13 am
cmpx
Compass Therapeutics And 2 More Compelling Penny Stocks [Yahoo! Finance]
High
Report
Compass Therapeutics And 2 More Compelling Penny Stocks [Yahoo! Finance]
4/2
08:11 am
cmpx
Compass Therapeutics, Inc. (NASDAQ: CMPX) was upgraded by analysts at Leerink Partners from a "market perform" rating to an "outperform" rating. They now have a $6.00 price target on the stock, up previously from $4.00.
High
Report
Compass Therapeutics, Inc. (NASDAQ: CMPX) was upgraded by analysts at Leerink Partners from a "market perform" rating to an "outperform" rating. They now have a $6.00 price target on the stock, up previously from $4.00.
4/1
10:31 pm
cmpx
Compass Therapeutics, Inc. (NASDAQ: CMPX) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $8.00 price target on the stock.
High
Report
Compass Therapeutics, Inc. (NASDAQ: CMPX) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $8.00 price target on the stock.
4/1
08:00 am
cmpx
Compass Therapeutics, Inc. (NASDAQ: CMPX) had its "buy" rating re-affirmed by analysts at D. Boral Capital. They now have a $32.00 price target on the stock.
Medium
Report
Compass Therapeutics, Inc. (NASDAQ: CMPX) had its "buy" rating re-affirmed by analysts at D. Boral Capital. They now have a $32.00 price target on the stock.
Date
Time
Symbol
Company Name
Action
%Chg
11/12/2024
08:00 am
cmpx
compass therapeutics, inc.
BEAT
Report
-5.3%
compass therapeutics, inc.
8/12/2024
08:00 am
cmpx
compass therapeutics, inc.
IN-LINE
Report
-5.0%
compass therapeutics, inc.
5/13/2024
08:00 am
cmpx
compass therapeutics, inc.
BEAT
Report
-0.6%
compass therapeutics, inc.
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
4/1
07:00 am
cmpx
Form 8-K Compass Therapeutics, For: Apr 01
High
Report
Form 8-K Compass Therapeutics, For: Apr 01
3/27
06:40 am
cmpx
Form S-8 Compass Therapeutics,
Medium
Report
Form S-8 Compass Therapeutics,
2/27
08:31 am
cmpx
Form 10-K Compass Therapeutics, For: Dec 31
Medium
Report
Form 10-K Compass Therapeutics, For: Dec 31
2/27
08:01 am
cmpx
Form 8-K Compass Therapeutics, For: Feb 27
Medium
Report
Form 8-K Compass Therapeutics, For: Feb 27
2/14
04:12 pm
cmpx
Form SCHEDULE 13G Compass Therapeutics, Filed by: MPM BioImpact LLC
Medium
Report
Form SCHEDULE 13G Compass Therapeutics, Filed by: MPM BioImpact LLC
2/13
05:12 pm
cmpx
Form 4 Compass Therapeutics, For: Feb 11 Filed by: Schuetz Thomas J.
Low
Report
Form 4 Compass Therapeutics, For: Feb 11 Filed by: Schuetz Thomas J.
2/13
05:12 pm
cmpx
Form 4 Compass Therapeutics, For: Feb 11 Filed by: Shin Barry
Low
Report
Form 4 Compass Therapeutics, For: Feb 11 Filed by: Shin Barry
2/13
05:12 pm
cmpx
Form 4 Compass Therapeutics, For: Feb 11 Filed by: LINDAHL RICHARD S
Low
Report
Form 4 Compass Therapeutics, For: Feb 11 Filed by: LINDAHL RICHARD S
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: